申请人:WHITBY RESEARCH, Inc.
公开号:EP0268220A2
公开(公告)日:1988-05-25
This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said systemic agent an effective amount of a membrane penetration enhancer having the structural formula
wherein R¹ and R² are independently selected from the group consisting of alkyl radicals and cycloalkyl radicals comprising from 1 to 20 carbon atoms and R is selected from the group consisting of alkyl radicals and cycloalkyl radicals comprising from 1 to 30 carbon atoms; provided, however, that the total number of carbon atoms in said compound is 15 or more and the total number of carbon atoms in R¹ and R² is 5 or more.
本发明涉及一种在透皮装置或制剂中通过人和动物的皮肤或粘膜施用包括治疗剂在内的全身活性制剂的方法,该方法包括与所述全身制剂一起局部施用有效量的具有结构式的膜渗透促进剂
其中 R¹ 和 R² 独立地选自由 1 至 20 个碳原子的烷基和环烷基组成的组,R 选自由 1 至 30 个碳原子的烷基和环烷基组成的组;但前提是所述化合物中的碳原子总数为 15 个或更多,且 R¹ 和 R² 中的碳原子总数为 5 个或更多。